Drug maker Junshi seeks Swiss cure for cash woes 亏损阴霾不散 君实发GDR筹34亿
The biotech aims to raise 3.4 billion yuan through Swiss GDRs in its second major fund-raising push in just over six months 这家生物制药公司计划到瑞士发行GDR筹资34亿元，是短短半年来的第二次大额融资。
Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.